Cardiac metastasis of lung cancer. A study of metastatic pathways and clinical manifestations

Abstract

Background. Although lung cancer frequently spreads to the heart, details of cardiac metastases of lung cancer have not been fully discussed. The authors attempted to elucidate the relationship between the mechanisms of cardiac metastasis and a variety of clinical manifestations caused by cardiac metastasis. Methods. Clinical and autopsy records were reviewed in 74 autopsied cases of lung cancer. In cases with cardiac metastasis, the metastatic pathways to the heart were determined by the macroscopic examinations, and the relationship between the metastatic pathways and the clinical manifestations were studied. Results. Metastases to the pericardium or heart were seen in 23 cases (31%). A lymphatic metastatic pathway was detected in 18 cases (hilar lymphatic routing in 12 cases, and mediastinal lymphatic routing in 6 cases), and a hematogenous metastatic pathway was detected in 5 cases. Malignant pericardial effusion was documented in 15 of 23 cases. The metastatic pathway in 14 of 15 cases was lymphatic (hilar lymphatic routing in 10 cases, and mediastinal lymphatic routing in 4 cases). Patients showing lymphatic metastasis had higher incidence of malignant pericardial effusion than those with hematogenous metastasis (P < 0.05). Of 23 cases of cardiac metastasis, myocardial infarction was found in 1 case, resulting from the compression of the coronary arteries by the tumor. Concurrent supraventricular arrhythmias were recorded in eight cases with cardiac metastasis. Patients with cardiac metastasis had higher incidence of arrhythmia than those without cardiac metastasis (P < 0.05). In cases of cardiac metastasis, patients with arrhythmia were older (P < 0.01) than those without arrhythmia. Conclusions. The authors concluded that the hilar lymphatic pathway is essential for early development of malignant pericardial effusion in lung cancer and that aging and cardiac metastasis may be responsible for arrhythmia in patients with lung cancer. Cancer 1992; 70:437–442.

Misdiagnosis Cardiac Metastasis Presented as a Pseudo-Infarction on Electrocardiography

“…8) Tamura, et al reported a high incidence (35%) of concurrent supraventricular arrhythmia including PSVT (8%) in their series. 10) Although PSVT was not proved to be related to myocardial invasion in this case, it was reasonably suspected in this elderly patient. Only Yao, et al reported a similar case that presented with both ST-elevation and PSVT.…”

“…6,7) An autopsy series determined that the incidence of cardiac metastasis in patients with malignant disease was as high as 22-31%. [8][9][10] Cardiac metastases, however, are difficult to diagnose before death, because there are frequently few typical signs that are indicative of cardiac metastasis and these signs are often clinically unapparent.…”

“…11) In patients with cardiac metastasis, the pericardium is the most frequent site of involvement, and patients typically present with clinical symptoms and signs of acute pericarditis. 10) In some cases, the patient presents with cardiac tamponade.…”

Metastatic Cardiac Tumor from Bronchogenic Carcinoma via Pulmonary Vein: A Case Report

“…According to study conducted by Tamura et al the incidence of cardiac & pericardiac metastases in patients with bronchogenic carcinoma was 17 to 31 % [9]. Only few cases of cardiac metastasis from bronchogenic carcinoma via…”

Epidemiology, risk factors, symptomatology, TNM classification of Non Small Cell Lung Cancer. An overview while waiting the 8th TNM classification

“…The heart or the pericardium may be affected in 20% of the cases either directly from tumor infiltration or indirectly because of lymphocytic or hematogenous metastases. Malignant pericardial effusion can be often in lymphatic spread of the tumor (33,40). Arrhythmias can also been present (40,41), while myocardial infarction has also been diagnosed as a result of the compression of the coronary arteries (40).…”